carbamazepine has been researched along with Infections, Plasmodium in 3 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe four patients with left temporal lobe epilepsy who developed psychosis, intermittent polydipsia and hyponatremia (PIP-syndrome) while being treated with carbamazepine." | 3.69 | Carbamazepine and PIP-syndrome in temporal lobe epilepsy. ( Schmitz, B; Trimble, MR, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cross, RM | 1 |
| Flanigan, DL | 1 |
| Monastyrskyi, A | 2 |
| LaCrue, AN | 2 |
| Sáenz, FE | 1 |
| Maignan, JR | 2 |
| Mutka, TS | 1 |
| White, KL | 1 |
| Shackleford, DM | 1 |
| Bathurst, I | 1 |
| Fronczek, FR | 1 |
| Wojtas, L | 1 |
| Guida, WC | 1 |
| Charman, SA | 1 |
| Burrows, JN | 1 |
| Kyle, DE | 2 |
| Manetsch, R | 2 |
| Brockmeyer, F | 1 |
| Zhao, Y | 1 |
| Maher, SP | 1 |
| Padin-Irizarry, V | 1 |
| Sakhno, YI | 1 |
| Parvatkar, PT | 1 |
| Asakawa, AH | 1 |
| Huang, L | 1 |
| Casandra, D | 1 |
| Mashkouri, S | 1 |
| Schmitz, B | 1 |
| Trimble, MR | 1 |
3 other studies available for carbamazepine and Infections, Plasmodium
| Article | Year |
|---|---|
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Paras | 2014 |
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Topics: Administration, Oral; Animals; Antimalarials; Cyclization; Disease Models, Animal; Ethers; Female; H | 2021 |
Carbamazepine and PIP-syndrome in temporal lobe epilepsy.
Topics: Anticonvulsants; Carbamazepine; Cholera; Craniocerebral Trauma; Drinking Behavior; Electroencephalog | 1995 |